Sanguine Biosciences Enhances Research Capabilities
New sample types strengthen support for autoimmune, dermatology, and inflammation research
Sanguine Biosciences, a leading provider of high-quality human biospecimens and real-world clinical data, has proudly announced the addition of two new sample types to its clinical biospecimen portfolio: Synovial Fluid and Skin Punch Biopsy collections. These innovative offerings are designed to enhance research efforts focused on understanding autoimmune, inflammatory, along with musculoskeletal and dermatological disorders.
Expanding Research Horizons with Synovial Fluid
With the introduction of Synovial Fluid, Sanguine aims to provide researchers access to fresh, high-quality samples collected from donors with ailments like rheumatoid arthritis, psoriatic arthritis, and gout. This opportunity allows for a deeper examination of disease mechanisms, delivering critical insights into cytokine profiles and immune responses.
Key Features of Synovial Fluid Samples
The collection process adheres to the highest standards, ensuring:
- Fresh or frozen synovial fluid collected under sterile conditions
- Donors specifically recruited based on disease indications
- The option for matched whole blood, plasma, serum, and PBMCs
- Compliance with IRB-approved and HIPAA-compliant procedures
Gerald Lee, Chief Product Officer at Sanguine, highlighted, "Access to high-integrity synovial fluid provides a direct insight into inflammatory biology, facilitating studies into therapeutic responses in joint diseases.”
Skin Punch Biopsy: A New Avenue for Dermatology
In addition to synovial fluid, Sanguine also introduces the Skin Punch Biopsy offering, which is suited for a range of dermatological conditions, including psoriasis and scleroderma. This new resource allows researchers to gather comprehensive clinical data, enabling them to track both disease progression and the effects of treatment over time.
Noteworthy Aspects of Skin Punch Biopsies
Features include:
- 2mm to 3mm diameter biopsies from disease-specific and control sites
- Detailed clinical metadata verified by electronic medical records
- Availability of fresh or frozen tissue options
- Prospectively collected samples tailored to protocol needs
Lee also emphasized the growing necessity for tissue insights in dermatology, stating, "These biopsies empower researchers to explore immune pathways and structural changes directly within diseased tissue.”
A Commitment to Patient-Centric Research
Sanguine's new offerings reflect its dedication to facilitating clinical research by fostering transparency and community engagement among participants. Sanguine harnesses advanced technology to streamline interactions with donors, allowing their easy participation in research initiatives. Through secure integration of electronic medical records (EMRs), Sanguine ensures that each biospecimen is accompanied by rich clinical data.
By combining clinical data with matched biospecimens, Sanguine provides researchers with comprehensive datasets that are essential for studies in autoimmune and inflammatory diseases. This methodology not only accelerates access to high-quality biospecimens and data but also maintains the integrity of clinic workflows and enhances the donor experience.
About Sanguine Biosciences
Sanguine Biosciences empowers pharmaceutical and biotech organizations by providing them with top-tier biospecimens and clinical data via a nationwide, participant-focused research network. With approval from relevant ethical boards and light-speed coordination, Sanguine streamlines translational research across diverse fields, including autoimmune diseases, oncology, and beyond.
Frequently Asked Questions
What new sample types has Sanguine introduced?
Sanguine has launched new offerings of Synovial Fluid and Skin Punch Biopsy collections to enhance research capabilities.
How does the Synovial Fluid collection aid researchers?
The Synovial Fluid collection helps researchers access high-quality samples for studying autoimmune and inflammatory joint diseases.
What diseases can be supported through the new Skin Punch Biopsy?
The Skin Punch Biopsy can be utilized for conditions such as psoriasis, lupus, and other chronic inflammatory skin disorders.
What supports Sanguine’s research initiatives?
Sanguine’s research is supported by a participant-centric approach and the ability to integrate EMR data with biospecimens.
Why are these new samples important for the scientific community?
These samples provide critical insights into disease mechanisms, allowing for better understanding and treatment of various health conditions.
